High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation

Francis E Sharkey, Irina Lytvak, Thomas J. Prihoda, Kermit V Speeg, W. Kenneth Washburn, Glenn A Halff

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Macrovesicular steatosis may be used to exclude potential donor livers from use in transplantation. Livers with more than 50% macrovesicular steatosis are believed to be at risk for delayed graft function and primary graft nonfunction. However, the significance of even extensive microsteatosis is uncertain. The hematoxylin and eosin-stained slides of postperfusion donor liver biopsies from 161 transplants were examined. The type of steatosis (macrovesicular, low-grade microvesicular, and high-grade microvesicular) was determined, and the extent of each type was semiquantitated into 3 groups (none, ≤50%, and >50%). These were analyzed in conjunction with the donor and recipient age and the recipient's sex and MELD score against postoperative outcome parameters, including serial measures of serum lactate, days in the intensive care unit and overall in hospital, and death less than 3 months posttransplant. High-grade microsteatosis usually coexisted with macrosteatosis and infrequently with low-grade microsteatosis. There was no significant association between the extent of either macrosteatosis or low-grade microsteatosis (even when >50%) and any of the outcome parameters. In contrast, the presence of high-grade microsteatosis was significantly associated with delayed hepatic function, but not with the other outcome parameters. Donor age greater than 60 years was associated with late postoperative rise in serum lactate, and higher recipient MELD score was associated with extended stay in the intensive care unit and in the hospital. In this patient population, the association of steatosis with adverse outcomes was largely restricted to delay in postoperative hepatic function, and was due to the subgroup that displayed high-grade microsteatosis.

Original languageEnglish (US)
Pages (from-to)1337-1342
Number of pages6
JournalHuman Pathology
Volume42
Issue number9
DOIs
StatePublished - Sep 2011

Fingerprint

Liver Transplantation
Tissue Donors
Liver
Intensive Care Units
Lactic Acid
Delayed Graft Function
Transplants
Hematoxylin
Eosine Yellowish-(YS)
Serum
Transplantation
Biopsy
Population

Keywords

  • Graft function
  • Liver transplantation
  • Macrosteatosis
  • Microsteatosis
  • Steatosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. / Sharkey, Francis E; Lytvak, Irina; Prihoda, Thomas J.; Speeg, Kermit V; Washburn, W. Kenneth; Halff, Glenn A.

In: Human Pathology, Vol. 42, No. 9, 09.2011, p. 1337-1342.

Research output: Contribution to journalArticle

Sharkey, Francis E ; Lytvak, Irina ; Prihoda, Thomas J. ; Speeg, Kermit V ; Washburn, W. Kenneth ; Halff, Glenn A. / High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. In: Human Pathology. 2011 ; Vol. 42, No. 9. pp. 1337-1342.
@article{78be0861814f4b65917a43f5b80e2f5a,
title = "High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation",
abstract = "Macrovesicular steatosis may be used to exclude potential donor livers from use in transplantation. Livers with more than 50{\%} macrovesicular steatosis are believed to be at risk for delayed graft function and primary graft nonfunction. However, the significance of even extensive microsteatosis is uncertain. The hematoxylin and eosin-stained slides of postperfusion donor liver biopsies from 161 transplants were examined. The type of steatosis (macrovesicular, low-grade microvesicular, and high-grade microvesicular) was determined, and the extent of each type was semiquantitated into 3 groups (none, ≤50{\%}, and >50{\%}). These were analyzed in conjunction with the donor and recipient age and the recipient's sex and MELD score against postoperative outcome parameters, including serial measures of serum lactate, days in the intensive care unit and overall in hospital, and death less than 3 months posttransplant. High-grade microsteatosis usually coexisted with macrosteatosis and infrequently with low-grade microsteatosis. There was no significant association between the extent of either macrosteatosis or low-grade microsteatosis (even when >50{\%}) and any of the outcome parameters. In contrast, the presence of high-grade microsteatosis was significantly associated with delayed hepatic function, but not with the other outcome parameters. Donor age greater than 60 years was associated with late postoperative rise in serum lactate, and higher recipient MELD score was associated with extended stay in the intensive care unit and in the hospital. In this patient population, the association of steatosis with adverse outcomes was largely restricted to delay in postoperative hepatic function, and was due to the subgroup that displayed high-grade microsteatosis.",
keywords = "Graft function, Liver transplantation, Macrosteatosis, Microsteatosis, Steatosis",
author = "Sharkey, {Francis E} and Irina Lytvak and Prihoda, {Thomas J.} and Speeg, {Kermit V} and Washburn, {W. Kenneth} and Halff, {Glenn A}",
year = "2011",
month = "9",
doi = "10.1016/j.humpath.2010.12.004",
language = "English (US)",
volume = "42",
pages = "1337--1342",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation

AU - Sharkey, Francis E

AU - Lytvak, Irina

AU - Prihoda, Thomas J.

AU - Speeg, Kermit V

AU - Washburn, W. Kenneth

AU - Halff, Glenn A

PY - 2011/9

Y1 - 2011/9

N2 - Macrovesicular steatosis may be used to exclude potential donor livers from use in transplantation. Livers with more than 50% macrovesicular steatosis are believed to be at risk for delayed graft function and primary graft nonfunction. However, the significance of even extensive microsteatosis is uncertain. The hematoxylin and eosin-stained slides of postperfusion donor liver biopsies from 161 transplants were examined. The type of steatosis (macrovesicular, low-grade microvesicular, and high-grade microvesicular) was determined, and the extent of each type was semiquantitated into 3 groups (none, ≤50%, and >50%). These were analyzed in conjunction with the donor and recipient age and the recipient's sex and MELD score against postoperative outcome parameters, including serial measures of serum lactate, days in the intensive care unit and overall in hospital, and death less than 3 months posttransplant. High-grade microsteatosis usually coexisted with macrosteatosis and infrequently with low-grade microsteatosis. There was no significant association between the extent of either macrosteatosis or low-grade microsteatosis (even when >50%) and any of the outcome parameters. In contrast, the presence of high-grade microsteatosis was significantly associated with delayed hepatic function, but not with the other outcome parameters. Donor age greater than 60 years was associated with late postoperative rise in serum lactate, and higher recipient MELD score was associated with extended stay in the intensive care unit and in the hospital. In this patient population, the association of steatosis with adverse outcomes was largely restricted to delay in postoperative hepatic function, and was due to the subgroup that displayed high-grade microsteatosis.

AB - Macrovesicular steatosis may be used to exclude potential donor livers from use in transplantation. Livers with more than 50% macrovesicular steatosis are believed to be at risk for delayed graft function and primary graft nonfunction. However, the significance of even extensive microsteatosis is uncertain. The hematoxylin and eosin-stained slides of postperfusion donor liver biopsies from 161 transplants were examined. The type of steatosis (macrovesicular, low-grade microvesicular, and high-grade microvesicular) was determined, and the extent of each type was semiquantitated into 3 groups (none, ≤50%, and >50%). These were analyzed in conjunction with the donor and recipient age and the recipient's sex and MELD score against postoperative outcome parameters, including serial measures of serum lactate, days in the intensive care unit and overall in hospital, and death less than 3 months posttransplant. High-grade microsteatosis usually coexisted with macrosteatosis and infrequently with low-grade microsteatosis. There was no significant association between the extent of either macrosteatosis or low-grade microsteatosis (even when >50%) and any of the outcome parameters. In contrast, the presence of high-grade microsteatosis was significantly associated with delayed hepatic function, but not with the other outcome parameters. Donor age greater than 60 years was associated with late postoperative rise in serum lactate, and higher recipient MELD score was associated with extended stay in the intensive care unit and in the hospital. In this patient population, the association of steatosis with adverse outcomes was largely restricted to delay in postoperative hepatic function, and was due to the subgroup that displayed high-grade microsteatosis.

KW - Graft function

KW - Liver transplantation

KW - Macrosteatosis

KW - Microsteatosis

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=80051685827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051685827&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2010.12.004

DO - 10.1016/j.humpath.2010.12.004

M3 - Article

C2 - 21420717

AN - SCOPUS:80051685827

VL - 42

SP - 1337

EP - 1342

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 9

ER -